Biopharmaceutical Research Company (BRC) Applauds Continued Congressional Efforts to Expand Cannabis Research. Read more →

George Hodgin, CEO of Biopharmaceutical Research Company, praises bill to reduce barriers to medicinal cannabis research. Read more →